Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials

Back

ESC Professional Premium Access

Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials

Session: What's new in lipid lowering?

Topic: Drug therapy

Speaker: Doctor P. Burger (Utrecht, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Pascal Burger

University Medical Center Utrecht, Utrecht (Netherlands (The))

0 follower

5 more presentations in this session

An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves potent and LDLR-independent liver editing in mouse models

Speaker: Doctor A. Khera (Boston, US)

Attainment of LDL-cholesterol goals in patients with previous myocardial infarction: a real-world cross-sectional analysis

Speaker: Mr D. Gomes (Lisbon, PT)

Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study.

Speaker: Associate Professor T. Osadnik (Zabrze, PL)

Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): Implications for the OCEAN(a)-Outcomes trial population

Speaker: Doctor B. Weber (Boston, US)

Effects of icosapent ethyl on residual cardiovascular risk according to predicted baseline risk: results from REDUCE-IT

Speaker: Doctor P. Burger (Utrecht, NL)

Access the full session

What's new in lipid lowering?

Speakers: Doctor P. Burger, Doctor A. Khera, Mr D. Gomes, Associate Professor T. Osadnik, Doctor B. Weber...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources